Dr Lalchandani Labs Ltd.
Fundamentals
- Market cap
- ₹6.12 cr
- P/E
- 97.12×
- ROE
- 4.19%
- Debt / equity
- 0.41
- 52-week range
- 6.46 — 21.22
Company snapshot
Dr Lalchandani Labs Ltd.
Hospitals
₹6 cr
P/E 101.59×
Latest quarter · Mar 2026
Sales₹2 cr
Net profit−₹0 cr
Op. margin−8.7%
EPS−₹0.15
Strength & growth
Debt / equity0.41×
Current ratio1.92×
Sales CAGR+3.5%
The timeline — 3 notes on Dr Lalchandani Labs Ltd.
June 2026
- 03 Jun 26 · 9:40 PM IST Brief Brief · Earnings · Micro cap
Dr Lalchandani Labs posts profit only because lenders waived ₹61 lacs in debt
Auditors qualified the accounts, flagging NPA classification and unpaid statutory dues since mid-2024. The company holds ₹4.14 cr in cash but won't pay.
- 03 Jun 26 · 9:31 PM IST Brief Brief · Earnings · Micro cap
Lalchandani Labs auditors flag defaults despite cash reserves
Auditors issued a qualified opinion on FY26 results, documenting loan defaults and missed statutory dues even as the company held cash.
- 03 Jun 26 · 9:31 PM IST Brief Brief · Earnings · Micro cap
Dr Lalchandani Labs survives on a one-time settlement. Auditors qualify the accounts.
A ₹61.08 lacs one-time settlement gain is the only thing standing between the company and an operational loss. Auditors flagged NPA classification and unpaid statutory dues.